DRK Research Solutions SA is your end-to-end CDMO partner. We advance pharmaceutical and biopharmaceutical products from early formulation through process validation, regulatory submission, and global commercial supply - with Swiss quality and global execution.
"At DRK, we don't just work for you - we work with you; combining Swiss quality with global agility to deliver excellence without exception."DRK Research Solutions SA
Our fully integrated CDMO platform eliminates the complexity of working across multiple vendors. From lab-scale development to commercial batch manufacturing, DRK provides seamless continuity at every stage.
Seamless advancement from early-stage formulation through process validation, regulatory submission, and commercial manufacturing with accelerated time to market.
Fully documented transition of data, materials, and process know-how to partner sites - safeguarding product integrity and long-term supply reliability.
Three flexible models: out-licensing with commercial supply, complete technology transfer, or a ready-to-submit regulatory dossier - tailored to your investment objectives.
Consistent, GMP-compliant manufacturing from engineering batches through full commercial-scale production - ensuring uninterrupted global supply.
Comprehensive IMP development, GMP clinical manufacturing, customised packaging, and integrated logistics across all clinical trial phases globally.
Comprehensive support across EMA, USFDA, MHRA, EAEU, and WHO - eCTD dossiers, bioequivalence coordination, and post-approval lifecycle management.
Every milestone is documented, reviewed, and approved before the next phase begins. Nothing is left to assumption - every decision is backed by data and multidisciplinary expert review.
Our scientific team brings focused capability in complex generics, niche products, and hybrid 505(b)(2) formulations across key therapeutic areas.
"DRK's scientific team brings deep formulation, analytical, and regulatory expertise across key therapeutic categories - with focused capability in complex generics and niche products."
Antibacterial, antiviral, antifungal agents
Antipsychotics, antidepressants, anxiolytics
Acne, psoriasis, eczema therapies
GERD, IBD, IBS, anti-emetics
Diabetes, dyslipidemia, obesity
Vitamins, probiotics, immunity boosters
Solid tumours, haematological malignancies
Glaucoma, dry eye, post-surgical care
NSAIDs, analgesics, rheumatology
Asthma, COPD, allergic rhinitis
Maternal, reproductive, general wellness
DRK is actively developing capability in monoclonal antibodies (mAbs), recombinant proteins, CAR-T therapies, and gene therapy - positioning for next-generation biologics programmes.
We combine scientific depth with integrated manufacturing capabilities - solving technical challenges and aligning each dosage form with its regulatory and commercial objectives.
DRK combines scientific expertise, regulatory intelligence, and agile project execution to deliver fully integrated CDMO solutions that reduce complexity and accelerate products to commercialisation.
Internationally benchmarked quality standards delivered across global markets.
Customised structures aligned with your programme stage and commercial objectives.
Milestone-driven execution minimising timeline risk with full regulatory compliance.
Streamlined multi-market submissions through a single fully integrated partner.
Proactive sourcing strategies ensuring uninterrupted product supply globally.
Stage-gated development with documented decision points and full transparency.
Active regulatory intelligence and dossier expertise across major global authorities - enabling sponsors to pursue multi-market approvals through a single integrated development partner.
Whether you are at pre-formulation stage or seeking a commercial manufacturing partner, our team of over 100 experts is ready to develop a solution tailored to your programme's specific requirements and timelines.
Global offices: Geneva (HQ) · Cambridge, UK · Virginia, USA · Lahore, Pakistan · Kuala Lumpur, Malaysia · Kathmandu, Nepal · Dubai, UAE
Tell us about your programme. We respond within one business day.
DRK Research Solutions SA - Chem. de la Blonde 38, 1253 Vandoeuvres, Geneva, Switzerland · info.ch@drkresearch.com · +41 22 575 27 35
